The Cancer Epigenetics Training Program Program provides postdoctoral fellows with in-depth training in multiple areas of cancer epigenetics, spanning from biochemistry, molecular and computational biology, to in vivo modeling, translational research, and social epigenomics. The program provides trainees with a platform through which they can develop successful careers as scientists, physicians, scientific administrators, and entrepreneurs that will identify novel agents and devises to treat cancer.
Federally funded by the NIH-NCI, Ruth L. Kirschstein National Research Service Award (T32) program, the Cancer Epigenetics program is led by Co-Directors, Maria Figueroa, M.D., Associate Professor, Department of Human Genetics; Co-Leader, Cancer Epigenetics Research Program and Lluis Morey, Ph.D., Assistant Professor, Department of Human Genetics. By bringing together an accomplished team, the goal is to train the future leaders in the field, who are poised to take new challenges in fighting against cancer through epigenetic studies.
The program supports two trainees per year and fellowships are two years in duration.
The Cancer Epigenetics training program exposes trainees to state-of-the-art resources and technology in cancer epigenetics research, such as specialized animal models, therapeutic targeting and personalized epigenetic therapies and complex genomics and bioinformatics. The main objective is that graduates of the program will continue to contribute throughout their independent careers to improve our understanding of epigenetic mechanisms underlying the regulation of oncogenic transcriptional programs and epigenome reprogramming, ultimately resulting in the discovery and development of novel therapeutic approaches that can be applied in a context of personalized medicine.
The program offers basic and advanced training in multidisciplinary cancer research, emphasizing fundamental knowledge in cancer epigenetics; provides trainees with basic and advanced research skills to conduct hypothesis-driven basic and translational studies via an individualized mentoring program; exposes trainees to a rich, diverse, and multidisciplinary training environment that will provide them with scientific depth, a robust mentoring network, and hands-on experience in cancer epigenetics; and provides trainees with career development that extends beyond the established academic curriculum through mentor-guided teaching experiences as well as skills-building workshops in oral and written communication.
This training program provides a two-year research training plan for postdoctoral fellows in research projects focused on cancer epigenetics. Fellows will follow a core curriculum, required activities and optional activities for a fruitful training experience.
- Weekly Cancer Epigenetics Journal Club
- Monthly Cancer Epigenetics Seminar Series
- Cancer Epigenetics Colloquium Series
- Chromatin Club
- Epigenomics Working Group meetings and Weekly Quantitative Science Clinic
- Scientific and Grant Writing Workshops
- Annual Miami Epigenetics & Cancer Symposium
Goals and Objectives
The curriculum is design to provide opportunities in a broad range of research training disciplines to our trainees that is suitable for team training and will be staffed with collaborating faculty possessing appropriate expertise and experience to support these training experiences. In addition, to ensure that the training requirements are beneficial but do not hinder their research progress, while specific courses are required, other courses can be elective, depending on each trainee’s specialization and future career paths.
Trainees will also benefit from common resources including
- Sylvester Comprehensive Cancer Center (SCCC) Seminars and Lectures
- Career Talks and Job Interview Skills
- SCCC Trainee Membership, SCCC Shared Resources, SCCC Annual Retreat and SCCC Travel Awards
- Dialogues in Research Ethics, LinkedIn Learning, Calder Library
- Leadership and Mentorship Courses
The major strengths of the Cancer Epigenetics training program include the robust cancer epigenetics-focused research at Sylvester, with cross-disciplinary research areas, diverse approaches, and extensive collaborations amongst the participating faculty. This collaborative environment amongst the participating faculty with cross-disciplinary research expertise is particularly valuable to enhance the research and professional skills of the trainees.
The group of internationally recognized leaders in translational research, health sciences and disparities research, and clinical trials also has a proven track record of outstanding mentorship. The program provides trainees with multi-disciplinary training, the mentorship team includes scientists within the major research areas in cancer epigenetics.
Using a two-tiered mentoring approach, the experience is designed so that every trainee will identify not only a basic science mentor, but a physician from Sylvester who can act as their clinical mentor. The goal of this approach is to allow our postdoctoral trainees to observe their clinical mentors as they work with patients in their subspecialties.
A rigorous selection criterion will be used to identify candidates likely to be successful in a career as an independent investigator. The training environment will enable trainees to work directly with preeminent T32 faculty mentors while engaging in several formal activities at the Sylvester Comprehensive Cancer Center.
- Citizens/noncitizen nationals of the United States or individuals who have been lawfully admitted for permanent residence at the time of appointment.
- Must be within 4 years of obtaining terminal degree (PhD) or within 4 years of residency or fellowship (MD)
- Must have 1st author publications from PhD thesis or prior postdoc work
- Candidates must be available for a 12‐month appointment and agree to undertake a minimum of two years of research, research training, or comparable experiences from the time of appointment.
- Those who have not had previous NRSA or T32 support.
- Application Form and Data Sheet
- CV in UM Format
- Research & Interest Goals (1-2 pages)
- Research & Goal Statement & Career Development Plan (1-2 pages)
- Nomination letter from Cancer Epigenetics T32 mentor (Candidates must be accepted into a mentor’s lab to qualify)
- 1-2 letters of reference
*One letter must be from a previous mentor
Please submit your application to
The Cancer Epigenetics Training Program
Office of Education & Training
Sylvester Comprehensive Cancer Center
- Anthony Capobianco, Ph.D., Department of Surgery
- Xi (Steven) Chen, Ph.D., Department of Public Health Sciences
- Wael El-Rifai, MD, Ph.D., Department of Surgery
- Maria Figueroa, M.D., Department of Human Genetics
- Sophia George, Ph.D., Department of Obstetrics & Gynecology
- Erin Kobetz, Ph.D., M.P.H., Departments of Medicine and Public Health Sciences
- Stephen Lee, Ph.D., Department of Biochemistry & Molecular Biology
- David Lombard, M.D., Ph.D., Department of Otolaryngology
- Oliver McDonald, M.D., Ph.D., Department of Pathology and Laboratory Medicine
- Zhipeng Meng, Ph.D., Department of Molecular & Cellular Pharmacology
- Lluis Morey, Ph.D., Department of Human Genetics
- Stephen Nimer, M.D., Department of Medicine
- J. Sunil Rao, Ph.D., Department of Public Health Sciences
- Jonathan Schatz, M.D., Department of Medicine
- Ramin Shiekhattar, Ph.D., Department of Human Genetics
- Stephen Schurer, Ph.D., Department of Molecular & Cellular Pharmacology
- Justin Taylor, M.D., Department of Medicine
- Luis Tuesta, Ph.D., Department of Psychiatry & Behavioral Sciences
- Ramiro Verdun, Ph.D., Department of Medicine
- Claes Wahlestedt, M.D., Ph.D., Department of Psychiatry & Behavioral Sciences
- Lily Wang, Ph.D., Department of Public Health Sciences
- Zheng Wang, Ph.D., Department of Computer Science
- Sion Williams, Ph.D., Department of Neurology
- Yanbin Zhang, Ph.D., Department of Biochemistry & Molecular Biology